Impact of Gut Microbiota on the Development of Diseases
DOI:
https://doi.org/10.12775/QS.2024.31.55903Keywords
metabolic disease, gut microbiota, dysbiosis, gut-brain axis, inflammatory diseases, cardiovascular diseases, neurodegenerative disease, fecal microbiota transplantationAbstract
Aim: The aim of this article is to review the latest scientific research on the influence of intestinal microbiota on the development of diseases. In this article we will discuss the importance of the intestinal microbiota, the differences in the composition of the microbiota between healthy and sick people and the relationship between the intestinal microbiota and metabolic, inflammatory, cardiovascular and neurodegenerative diseases.
Abbreviated description of the state of knowledge: The gut microbiota plays a key role in human health by influencing the development and progression of various diseases. Numerous studies have shown that an imbalance in gut microbiota, called dysbiosis, may be linked to a number of conditions. Intestinal microflora interacts with the immune system, modulates inflammation and influences metabolic pathways, which emphasizes its importance in the development of diseases.
Conclusions: Intestinal microflora is crucial to health, regulating immune, metabolic and neurological functions. Dysbiosis, i.e. disturbance of the balance of intestinal microflora, is associated with diseases such as type 2 diabetes, obesity, inflammatory bowel diseases, allergies, autoimmune diseases and neuropsychiatric disorders. Healthy microflora, influenced by diet, pH and nutrients, are essential for metabolism, immune system regulation and neuronal communication. Recently, scientists have become interested in the possibility of using this knowledge in treatment. Appropriate dietary management, probiotic supplementation and fecal microflora transplantation show promising potential. Future research should focus on elucidating the specific mechanisms by which the gut microbiota influences disease processes and developing targeted therapies to exploit the therapeutic potential of the microbiota.
References
Jandhyala SM, Talukdar R, Subramanyam C, et al. Role of the normal gut microbiota. World J Gastroenterol. 2015 Aug 7;21(29):8787-803. PMID: 26269668; PMCID: PMC4528021. https://doi.org/10.3748/wjg.v21.i29.8787
Milani C, Duranti S, Bottacini F, et al. The First Microbial Colonizers of the Human Gut: Composition, Activities, and Health Implications of the Infant Gut Microbiota. Microbiol Mol Biol Rev. 2017 Nov 8;81(4):e00036-17. PMID: 29118049; PMCID: PMC5706746. https://doi.org/10.1128/MMBR.00036-17
Adak A, Khan MR. An insight into gut microbiota and its functionalities. Cell Mol Life Sci. 2019 Feb;76(3):473-493. PMID: 30317530. https://doi.org/10.1007/s00018-018-2943-4
Strandwitz P. Neurotransmitter modulation by the gut microbiota. Brain Res. 2018 Aug 15;1693(Pt B):128-133. PMID: 29903615; PMCID: PMC6005194. https://doi.org/10.1016/j.brainres.2018.03.015
Fan L, Xia Y, Wang Y, et al. Gut microbiota bridges dietary nutrients and host immunity. Sci China Life Sci. 2023 Nov;66(11):2466-2514. Epub 2023 Jun 5. PMID: 37286860; PMCID: PMC10247344.). https://doi.org/10.1007/s11427-023-2346-1
Zmora N, Suez J, Elinav E. You are what you eat: diet, health and the gut microbiota. Nat Rev Gastroenterol Hepatol. 2019 Jan;16(1):35-56. PMID: 30262901. https://doi.org/10.1038/s41575-018-0061-2
Liu BN, Liu XT, Liang ZH, et al. Gut microbiota in obesity. World J Gastroenterol. 2021 Jul 7;27(25):3837-3850. PMID: 34321848; PMCID: PMC8291023. https://doi.org/10.3748/wjg.v27.i25.3837
Gomes AC, Hoffmann C, Mota JF. The human gut microbiota: Metabolism and perspective in obesity. Gut Microbes. 2018 Jul 4;9(4):308-325. Epub 2018 May 24. PMID: 29667480; PMCID: PMC6219651. https://doi.org/10.1080/19490976.2018.1465157.
Cox AJ, West NP, Cripps AW. Obesity, inflammation, and the gut microbiota. Lancet Diabetes Endocrinol. 2015 Mar;3(3):207-15. Epub 2014 Jul 22. PMID: 25066177. https://doi.org/10.1016/S2213-8587(14)70134-2
Green M, Arora K, Prakash S. Microbial Medicine: Prebiotic and Probiotic Functional Foods to Target Obesity and Metabolic Syndrome. Int J Mol Sci. 2020 Apr 21;21(8):2890. PMID: 32326175; PMCID: PMC7215979. https://doi.org/10.3390/ijms21082890
Leong KSW, Jayasinghe TN, Wilson BC, et al. Effects of Fecal Microbiome Transfer in Adolescents With Obesity: The Gut Bugs Randomized Controlled Trial. JAMA Netw Open. 2020 Dec 1;3(12):e2030415. PMID: 33346848; PMCID: PMC7753902. https://doi.org/10.1001/jamanetworkopen.2020.30415
Yu EW, Gao L, Stastka P, et al. Fecal microbiota transplantation for the improvement of metabolism in obesity: The FMT-TRIM double-blind placebo-controlled pilot trial. PLoS Med. 2020 Mar 9;17(3):e1003051. PMID: 32150549; PMCID: PMC7062239. https://doi.org/10.1371/journal.pmed.1003051
Aron-Wisnewsky J, Clément K, Nieuwdorp M. Fecal Microbiota Transplantation: a Future Therapeutic Option for Obesity/Diabetes? Curr Diab Rep. 2019 Jun 27;19(8):51. PMID: 31250122. https://doi.org/10.1007/s11892-019-1180-z
Zecheng L, Donghai L, Runchuan G, et al. Fecal microbiota transplantation in obesity metabolism: A meta analysis and systematic review. Diabetes Res Clin Pract. 2023 Aug;202:110803. Epub 2023 Jun 24. PMID: 37356723. https://doi.org/10.1016/j.diabres.2023.110803
Iatcu CO, Steen A, Covasa M. Gut Microbiota and Complications of Type-2 Diabetes. Nutrients. 2021 Dec 30;14(1):166. PMID: 35011044; PMCID: PMC8747253. https://doi.org/10.3390/nu14010166
Gurung M, Li Z, You H, et al. Role of gut microbiota in type 2 diabetes pathophysiology. EBioMedicine. 2020 Jan;51:102590. Epub 2020 Jan 3. PMID: 31901868; PMCID: PMC6948163. https://doi.org/10.1016/j.ebiom.2019.11.051
Haneishi Y, Furuya Y, Hasegawa M, et al. Inflammatory Bowel Diseases and Gut Microbiota. Int J Mol Sci. 2023 Feb 14;24(4):3817. PMID: 36835245; PMCID: PMC9958622. https://doi.org/10.3390/ijms24043817
Guan Z, Luo L, Liu S, et al. The Role of Depletion of Gut Microbiota in Osteoporosis and Osteoarthritis: A Narrative Review. Front Endocrinol (Lausanne). 2022 Mar 28;13:847401. PMID: 35418947; PMCID: PMC8996773. https://doi.org/10.3389/fendo.2022.847401
Qiu P, Ishimoto T, Fu L, Zhang J, Zhang Z, Liu Y. The Gut Microbiota in Inflammatory Bowel Disease. Front Cell Infect Microbiol. 2022 Feb 22;12:733992. PMID: 35273921; PMCID: PMC8902753. https://doi.org/10.3389/fcimb.2022.733992
Haneishi Y, Furuya Y, Hasegawa M, et al. Inflammatory Bowel Diseases and Gut Microbiota. Int J Mol Sci. 2023 Feb 14;24(4):3817. PMID: 36835245; PMCID: PMC9958622. https://doi.org/10.3390/ijms24043817
Chen L, Wang J. Gut microbiota and inflammatory bowel disease. WIREs Mech Dis. 2022 Mar;14(2):e1540. Epub 2021 Oct 15. PMID: 35266651. https://doi.org/10.1002/wsbm.1540
Ford AC, Sperber AD, Corsetti M, et al. Irritable bowel syndrome. Lancet. 2020 Nov 21;396(10263):1675-1688. Epub 2020 Oct 10. PMID: 33049223. https://doi.org/10.1016/S0140-6736(20)31548-8
Hillestad EMR, van der Meeren A, Nagaraja BH, et al. Gut bless you: The microbiota-gut-brain axis in irritable bowel syndrome. World J Gastroenterol. 2022 Jan 28;28(4):412-431. PMID: 35125827; PMCID: PMC8790555. https://doi.org/10.3748/wjg.v28.i4.412
Canakis A, Haroon M, Weber HC. Irritable bowel syndrome and gut microbiota. Curr Opin Endocrinol Diabetes Obes. 2020 Feb;27(1):28-35. PMID: 31789724. https://doi.org/10.1097/MED.0000000000000523
Mamieva Z, Poluektova E, Svistushkin V, Sobolev V, Shifrin O, Guarner F, Ivashkin V. Antibiotics, gut microbiota, and irritable bowel syndrome: What are the relations? World J Gastroenterol. 2022 Mar 28;28(12):1204-1219. PMID: 35431513; PMCID: PMC8968486. https://doi.org/10.3748/wjg.v28.i12.1204
Zhou W, Cheng Y, Zhu P, et al. Implication of Gut Microbiota in Cardiovascular Diseases. Oxid Med Cell Longev. 2020 Sep 26;2020:5394096. PMID: 33062141; PMCID: PMC7533754. https://doi.org/10.1155/2020/5394096
Tang WH, Kitai T, Hazen SL. Gut Microbiota in Cardiovascular Health and Disease. Circ Res. 2017 Mar 31;120(7):1183-1196. PMID: 28360349; PMCID: PMC5390330. https://doi.org/10.1161/CIRCRESAHA.117.309715
Jin M, Qian Z, Yin J, et al. The role of intestinal microbiota in cardiovascular disease. J Cell Mol Med. 2019 Apr;23(4):2343-2350. Epub 2019 Feb 3. PMID: 30712327; PMCID: PMC6433673. https://doi.org/10.1111/jcmm.14195
Witkowski M, Weeks TL, Hazen SL. Gut Microbiota and Cardiovascular Disease. Circ Res. 2020 Jul 31;127(4):553-570. Epub 2020 Jul 30. PMID: 32762536; PMCID: PMC7416843. https://doi.org/10.1161/CIRCRESAHA.120.316242
Anselmi G, Gagliardi L, Egidi G, et al. Gut Microbiota and Cardiovascular Diseases: A Critical Review. Cardiol Rev. 2021 Jul-Aug 01;29(4):195-204. PMID: 32639240. https://doi.org/10.1097/CRD.0000000000000327
Singh MP, Chakrabarty R, Shabir S, et al. Influence of the Gut Microbiota on the Development of Neurodegenerative Diseases. Mediators Inflamm. 2022 Sep 30;2022:3300903. PMID: 36248189; PMCID: PMC9553457. https://doi.org/10.1155/2022/3300903
Marizzoni M, Provasi S, Cattaneo A, Frisoni GB. Microbiota and neurodegenerative diseases. Curr Opin Neurol. 2017 Dec;30(6):630-638. PMID: 28906270. https://doi.org/10.1097/WCO.0000000000000496
Gomez ABM, Vera VMS, Salluco NFC, Copa JBM. Influencia de la microbiota intestinal en la enfermedad de Parkinson. Revisión. Revista Peruana de Ciencias de la Salud [Internet]. 2023 Oct 15 [cited 2023 Nov 30];5(4). https://doi.org/10.37711/rpcs.2023.5.3.422
Solch RJ, Aigbogun JO, Voyiadjis AG, Talkington GM, Darensbourg RM, O'Connell S, Pickett KM, Perez SR, Maraganore DM. Mediterranean diet adherence, gut microbiota, and Alzheimer's or Parkinson's disease risk: A systematic review. J Neurol Sci. 2022 Mar 15;434:120166. Epub 2022 Jan 26. PMID: 35144237. https://doi.org/10.1016/j.jns.2022.120166
Flowers SA, Ellingrod VL. The Microbiome in Mental Health: Potential Contribution of Gut Microbiota in Disease and Pharmacotherapy Management. Pharmacotherapy. 2015 Oct;35(10):910-6. PMID: 26497477. https://doi.org/10.1002/phar.1640
Pusceddu MM, Del Bas JM. The role of the gut microbiota in the pathophysiology of mental and neurological disorders. Psychiatr Genet. 2020 Aug;30(4):87-100. PMID: 32459708. https://doi.org/10.1097/YPG.0000000000000255
Generoso JS, Giridharan VV, Lee J, et al. The role of the microbiota-gut-brain axis in neuropsychiatric disorders. Braz J Psychiatry. 2021 May-Jun;43(3):293-305. PMID: 32667590; PMCID: PMC8136391. https://doi.org/10.1590/1516-4446-2020-0987
Xiong RG, Li J, Cheng J, et al.The Role of Gut Microbiota in Anxiety, Depression, and Other Mental Disorders as Well as the Protective Effects of Dietary Components. Nutrients. 2023 Jul 23;15(14):3258. PMCID: PMC10384867. https://doi.org/10.3390/nu15143258
Misra S, Mohanty D. Psychobiotics: A new approach for treating mental illness? Crit Rev Food Sci Nutr. 2019;59(8):1230-1236. Epub 2017 Nov 30. PMID: 29190117. https://doi.org/10.1080/10408398.2017.1399860
Taheri S, Khomeiri M. Psychobiotics and Brain-Gut Microbiota Axis. Iran J Med Microbiol 2019; 13 (1) :1-13. https://doi.org/10.30699/ijmm.13.1.1
Halverson T, Alagiakrishnan K. Gut microbes in neurocognitive and mental health disorders. Ann Med. 2020 Dec;52(8):423-443. Epub 2020 Aug 31. PMID: 32772900; PMCID: PMC7877977. https://doi.org/10.1080/07853890.2020.1808239
Wong CC, Yu J. Gut microbiota in colorectal cancer development and therapy. Nat Rev Clin Oncol. 2023 Jul;20(7):429-452. Epub 2023 May 11. PMID: 37169888. https://doi.org/10.1038/s41571-023-00766-x
Park EM, Chelvanambi M, Bhutiani N, Kroemer G, Zitvogel L, Wargo JA. Targeting the gut and tumor microbiota in cancer. Nat Med. 2022 Apr;28(4):690-703. Epub 2022 Apr 19. PMID: 35440726. https://doi.org/10.1038/s41591-022-01779-2
Bai X, Wei H, Liu W, et al. Cigarette smoke promotes colorectal cancer through modulation of gut microbiota and related metabolites. Gut. 2022 Dec;71(12):2439-2450. Epub 2022 Apr 6. PMID: 35387878; PMCID: PMC9664112. https://doi.org/10.1136/gutjnl-2021-325021
Qu R, Zhang Y, Ma Y et al. Role of the Gut Microbiota and Its Metabolites in Tumorigenesis or Development of Colorectal Cancer. Adv Sci (Weinh). 2023 Aug;10(23):e2205563. Epub 2023 Jun 1. PMID: 37263983; PMCID: PMC10427379. https://doi.org/10.1002/advs.202205563
Meng C, Bai C, Brown TD, Hood LE, Tian Q. Human Gut Microbiota and Gastrointestinal Cancer. Genomics Proteomics Bioinformatics. 2018 Feb;16(1):33-49. Epub 2018 Feb 21. PMID: 29474889; PMCID: PMC6000254. https://doi.org/10.1016/j.gpb.2017.06.002
Zhou CB, Zhou YL, Fang JY. Gut Microbiota in Cancer Immune Response and Immunotherapy. Trends Cancer. 2021 Jul;7(7):647-660. Epub 2021 Mar 2. PMID: 33674230. https://doi.org/10.1016/j.trecan.2021.01.010
Long Y, Tang L, Zhou Y, et al. Causal relationship between gut microbiota and cancers: a two-sample Mendelian randomisation study. BMC Med. 2023 Feb 21;21(1):66. PMID: 36810112; PMCID: PMC9945666. https://doi.org/10.1186/s12916-023-02761-6
Perler BK, Friedman ES, Wu GD. The Role of the Gut Microbiota in the Relationship Between Diet and Human Health. Annu Rev Physiol. 2023 Feb 10;85:449-468. Epub 2022 Nov 14. PMID: 36375468. https://doi.org/10.1093/advances/nmy078
Bibbò S, Ianiro G, Giorgio V, et al. The role of diet on gut microbiota composition. Eur Rev Med Pharmacol Sci. 2016 Nov;20(22):4742-4749. PMID: 27906427.
Li C, Niu Z, Zou M, et al. Probiotics, prebiotics, and synbiotics regulate the intestinal microbiota differentially and restore the relative abundance of specific gut microorganisms. J Dairy Sci. 2020 Jul;103(7):5816-5829. Epub 2020 May 14. Erratum in: J Dairy Sci. 2020 Dec;103(12):12159. PMID: 32418689. https://doi.org/10.3168/jds.2019-18003
Upasana. Application of Probiotics, Prebiotics and Synbiotics in Maintaining Gut Health. IJND [Internet]. 2022 Jul. 13 [cited 2024 May 21];59(3):388-97. https://doi.org/10.21048/IJND.2022.59.3.29516
Jung HY, Kim KW. An Evidence-Based Review of Probiotics and Prebiotics. Sci Insights [Internet]. 2022 May 30 [cited 2024 May 21];40(6):527-31. https://doi.org/10.15354/si.22.re055
Yang L, Bajinka O, Jarju PO, et al. The varying effects of antibiotics on gut microbiota. AMB Express. 2021 Aug 16;11(1):116. PMID: 34398323; PMCID: PMC8368853. https://doi.org/10.1186/s13568-021-01274-w
Nurgaziyev M, Sergazy S, Chulenbayeva L, Nurgozhina A, Gulyayev A, Kozhakhmetov S, Kartbayeva G, Kushugulova A. THE EFFECTS OF ANTIBIOTICS ON THE GUT MICROBIOME AND THE IMMUNE SYSTEM (Review). Georgian Med News. 2020 Jun;(303):167-173. PMID: 32841200.
Ianiro G, Tilg H, Gasbarrini Antibiotics as deep modulators of gut microbiota: between good and evilGut 2016;65:1906-1915. https://doi.org/10.1136/gutjnl-2016-312297
Kesavelu D, Jog P. Current understanding of antibiotic-associated dysbiosis and approaches for its management. Ther Adv Infect Dis. 2023 Feb 24;10:20499361231154443. PMID: 36860273; PMCID: PMC9969474. https://doi.org/10.1177/20499361231154443
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Karolina Winiarek, Martyna Michalska, Wiktor Wardyn, Cezary Guzowski, Joanna Anna Murawska, Daria Ziemińska, Rafał Burczyk, Kornelia Kędziora-Kornatowska

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Stats
Number of views and downloads: 129
Number of citations: 0